Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alun R Barnard

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2015
Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerizationPeter Charbel Issa, Alun R Barnard, Philipp Herrmann, et al.
Molecular Therapy. Methods & Clinical Development|May 1, 2018
The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by <i>In Vitro</i> Prenylation of RAB6AMaria I Patrício, Alun R Barnard, Christopher I Cox, et al.
Human Gene Therapy|May 13, 2020
Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine ModelHarry O Orlans, Alun R Barnard, Maria I Patrício, et al.
International Journal of Molecular Sciences|January 30, 2020
RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequencesLewis E Fry, Caroline F Peddle, Alun R Barnard, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human RetinaMaria I Patrício, Alun R Barnard, Harry O Orlans, et al.
International Journal of Molecular Sciences|July 18, 2020
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene TherapyLaurel C Chandler, Imran H Yusuf, Michelle E McClements, et al.
Seizure|January 26, 2018
A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell lineMaria I Patrício, Alun R Barnard, Alexander L Green, et al.
The CRISPR Journal|August 25, 2020
Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing EfficiencyLewis E Fry, Caroline F Peddle, Marta Stevanovic, et al.
Investigative Ophthalmology & Visual Science|June 28, 2019
Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin MutationHarry O Orlans, Jonathon Merrill, Alun R Barnard, et al.
Nature Communications|August 17, 2021
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosaHarry O Orlans, Michelle E McClements, Alun R Barnard, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2015
Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerizationPeter Charbel Issa, Alun R Barnard, Philipp Herrmann, et al.
Molecular Therapy. Methods & Clinical Development|May 1, 2018
The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by <i>In Vitro</i> Prenylation of RAB6AMaria I Patrício, Alun R Barnard, Christopher I Cox, et al.
Human Gene Therapy|May 13, 2020
Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine ModelHarry O Orlans, Alun R Barnard, Maria I Patrício, et al.
International Journal of Molecular Sciences|January 30, 2020
RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequencesLewis E Fry, Caroline F Peddle, Alun R Barnard, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human RetinaMaria I Patrício, Alun R Barnard, Harry O Orlans, et al.
International Journal of Molecular Sciences|July 18, 2020
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene TherapyLaurel C Chandler, Imran H Yusuf, Michelle E McClements, et al.
Seizure|January 26, 2018
A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell lineMaria I Patrício, Alun R Barnard, Alexander L Green, et al.
The CRISPR Journal|August 25, 2020
Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing EfficiencyLewis E Fry, Caroline F Peddle, Marta Stevanovic, et al.
Investigative Ophthalmology & Visual Science|June 28, 2019
Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin MutationHarry O Orlans, Jonathon Merrill, Alun R Barnard, et al.
Nature Communications|August 17, 2021
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosaHarry O Orlans, Michelle E McClements, Alun R Barnard, et al.
Pageof 7